Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-12-19)Premium Content

Achillion Pharmaceuticals Inc (ACHN)

2015-02-28@20:56:19 ET
Achillion Pharmaceuticals, Inc.Corporate Event Announcement Notice (WSH)

2015-02-28@20:37:00 ET
Achillion Pharmaceuticals, Inc.Corporate Event Announcement Notice (WSH)

2015-02-26@20:38:27 ET
Achillion Pharmaceuticals, Inc.Corporate Event Announcement Notice (WSH)

2015-02-26@15:42:27 ET
Achillion Pharmaceuticals (ACHN) Showing Bearish Technicals With Support At $11.95 (FBM)

2015-02-24@15:26:26 ET
Potential Achillion Pharmaceuticals (ACHN) Trade Targets 12.20% Return (FBM)

2015-02-23@11:38:22 ET
Achillion Pharmaceuticals (ACHN) Trading Near $12.75 Resistance Level (FBM)

2015-02-19@05:35:28 ET
Achillion Pharmaceuticals completes public offering at USD10.25 per share (MTO)

2015-02-18@16:35:14 ET
Achillion Pharmaceuticals Announces Closing of Public Offering of Common Stock (PMZ)

2015-02-17@13:41:57 ET
Achillion Pharmaceuticals (ACHN) Trading Near $11.51 Resistance Level (FBM)

2015-02-13@02:51:20 ET
8-K: ACHILLION PHARMACEUTICALS INC (EDK)

2015-02-12@15:05:01 ET
Achillion Pharmaceuticals prices $123 million public offering of common stock (DTF)

2015-02-12@10:51:09 ET
Achillion Pharmaceuticals (ACHN) Showing Resistance Near $11.93 (FBM)

2015-02-12@06:01:50 ET
Achillion Pharmaceuticals prices public offering of 12m common stock (MTO)

2015-02-12@05:41:21 ET
Wall St. ends down on Greece, China worries (ABW)

2015-02-11@23:59:09 ET
Achillion Pharmaceuticals Announces Pricing of Public Offering of Common Stock (PMZ)

2015-02-11@09:33:13 ET
Potential Achillion Pharmaceuticals (ACHN) Trade Has 48.78% Downside Protection (FBM)

2015-02-11@09:31:00 ET
Critical Alerts For Transocean, Crane, Achillion Pharmaceuticals, Endocyte and Monster Beverage Released By InvestorsObserver (PRN)

2015-02-11@05:53:03 ET
Achillion Pharmaceuticals plans to launch public offering of 10m common shares (MTO)

2015-02-11@05:25:32 ET
Achillion announces encouraging results from Phase II HCV infection study (DTM)

2015-02-10@16:08:11 ET
Achillion Pharmaceuticals Announces Proposed Public Offering of Common Stock (PMZ)